Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥50 years.
Sheryl A KlubergAndrew L SimonSarah M AlamAlexander PetersCasie HorganDongdong LiErick MoyneurElizabeth Messenger-JonesRichard PlattCheryl N McMahill-WalravenDjeneba Audrey DjiboKimberly DanielsAziza Jamal-AllialClaire H PernarNajat J ZiyadehQianli MaMano SelvanO'Mareen SpenceDriss OraichiHarry SeifertValentine FranckSusan GambleHuifeng YunPublished in: Seminars in arthritis and rheumatism (2024)
In a population of US adults aged ≥50 years, there was no statistically significant increase in the risk of gout during the 30 days immediately after RZV exposure, compared with a subsequent 30-day CW.
Keyphrases